In the context of IBD and colorectal cancer prevention, this includes nutraceuticals such as kynurenic acid, quercetin, curcumin, and probiotics, which modulate AhR and GPR35 signaling pathways [74,75,76,77]. This evidence concerns the gene GPR35 and inflammatory bowel disease.